CGTX logo

Cognition Therapeutics (CGTX)

Profile

Full Name

Cognition Therapeutics, Inc.

Ticker Symbol

CGTX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

October 8, 2021

Indexes

Not included

Website

http://www.cogrx.com

Employees

25

Key Details

Price

$0.34(+7.37%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.86(0.00% YoY)

PE ratio

-

Next earnings date

Aug 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.34
    CGTX price is $0.34

    30-Day Relative Volume

    1.00
    CGTX 30-day relative volume is 1.00

    Price Performance

    Price Most recent change

    +7.37%
    CGTX price was up +7.37% on Jul 2, 2025

    Price YTD change

    -52.21%
    CGTX price is down -52.21% since January 1st

    Price 1-year change

    -81.07%
    CGTX price is down -81.07% year-on-year

    Price 3-year change

    -85.11%
    CGTX price is down -85.11% over the past 3 years

    Price Range

    Price All-time high

    $13.80
    CGTX price is currently -97.57% below its historical high of $13.80

    Price 3-year low

    $0.22
    CGTX price is currently +50.90% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $20.77M
    CGTX market capitalization is $20.77 million

    Market cap 3-year change

    -59.16%
    CGTX market capitalization is down -59.16% over the past 3 years

    Market cap All-time high

    $277.40M
    CGTX market capitalization is currently -92.51% below its historical high of $277.40 million

    Market cap sector rank

    25.78%
    CGTX market capitalization is higher than 25.78% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +54.55%
    CGTX shares outstanding is up +54.55% year-on-year

    Shares Outstanding 3-Year Change

    +174.33%
    CGTX shares outstanding is up +174.33% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.40
    CGTX beta is 1.40

    200-day SMA

    $0.47
    CGTX price is currently -29.31% below its 200-day simple moving average

    50-day SMA

    $0.33
    CGTX price is currently +1.64% above its 50-day simple moving average

    RSI

    56.10
    CGTX 14-day relative strength index is 56.10

    Volume

    1.00
    CGTX 30-day relative volume is 1.00

    ATR

    $0.03
    CGTX average true range is $0.03

    10-day Historical Volatility

    115.07%
    CGTX 10-day historical volatility is 115.07%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    -
    CGTX annual revenue value is unknown

    Revenue Analysts estimate

    -
    CGTX annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -
    CGTX annual revenue 1-year change is unknown

    Revenue Sector rank

    -
    CGTX annual revenue is unknown

    EPS

    EPS

    -$0.86
    CGTX annual earnings per share is -$0.86

    EPS Analysts estimate

    -$0.43
    CGTX annual earnings per share is currently +101.17% higher than the consensus analysts' forecast

    EPS 1-year change

    0%
    CGTX {parameterFullLabel} has remained unchanged year-on-year

    EPS Sector rank

    59.56%
    CGTX annual earnings per share is higher than 59.56% of companies in Healthcare sector

    Profit

    Gross profit

    -
    CGTX annual gross profit value is unknown

    Gross margin

    -
    CGTX annual gross profit margin value is unknown

    Operating profit

    -$34.42M
    CGTX annual operating income is -$34.42 million

    Operating margin

    -
    CGTX annual operating profit margin value is unknown

    Net income

    -$33.97M
    CGTX annual net profit is -$33.97 million

    Net margin

    -
    CGTX annual net profit margin value is unknown

    Expenses

    Total expenses

    $34.42M
    CGTX annual total expenses is $34.42 million

    Operating expenses

    $34.42M
    CGTX annual total operating expenses is $34.42 million

    Cost of goods sold

    -
    CGTX annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $12.29M
    CGTX annual SGA is $12.29 million

    Depreciation and amortization

    $266.00K
    CGTX annual depreciation & amortization is $266.00 thousand

    Interest expense

    $25.00K
    CGTX annual interest expense is $25.00 thousand

    Income tax

    -
    CGTX annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$33.95M
    CGTX annual earnings before interest & taxes is -$33.95 million

    EBITDA

    -$33.68M
    CGTX annual EBITDA is -$33.68 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $30.23M
    CGTX annual total assets is $30.23 million

    Non current assets

    $679.00K
    CGTX annual long term assets is $679.00 thousand

    Current assets

    $29.55M
    CGTX annual total current assets is $29.55 million

    Cash and cash equivalents

    $25.01M
    CGTX annual cash & cash equivalents is $25.01 million

    Accounts receivable

    -
    CGTX annual accounts receivable value is unknown

    Inventory

    -
    CGTX annual inventory value is unknown

    Liabilities

    Total liabilities

    $11.48M
    CGTX annual total liabilities is $11.48 million

    Long term liabilities

    $342.00K
    CGTX annual total long term liabilities is $342.00 thousand

    Current liabilities

    $11.14M
    CGTX annual total current liabilities is $11.14 million

    Accounts payable

    $1.98M
    CGTX annual accounts payable is $1.98 million

    Debt

    Total debt

    $814.00K
    CGTX annual total debt is $814.00 thousand

    Total debt 1-year change

    -34.25%
    CGTX annual total debt is down -34.25% year-on-year

    Long term debt

    $342.00K
    CGTX annual long term debt is $342.00 thousand

    Short term debt

    $472.00K
    CGTX annual short term debt is $472.00 thousand

    Equity & Capital

    Shareholders equity

    $18.75M
    CGTX annual stockholders equity is $18.75 million

    Book value

    $18.75M
    CGTX annual book value is $18.75 million

    Retained earnings

    -$175.16M
    CGTX annual retained earnings is -$175.16 million

    Working capital

    $18.41M
    CGTX annual working capital is $18.41 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$28.47M
    CGTX annual cash flow from operations is -$28.47 million

    Cash from operations 1-year change

    -77.76%
    CGTX annual cash flow from operations is down -77.76% year-on-year

    Cash from investing

    -$4000.00
    CGTX annual cash flow from investing activities is -$4000.00

    Cash from investing 1-year change

    +97.28%
    CGTX annual cash flow from investing activities is up +97.28% year-on-year

    Cash from financing

    $23.57M
    CGTX annual cash flow from financing activities is $23.57 million

    Cash from financing 1-year change

    +421.23%
    CGTX annual cash flow from financing activities is up +421.23% year-on-year

    CAPEX

    CAPEX

    -
    CGTX annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    CGTX annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$28.48M
    CGTX annual free cash flow is -$28.48 million

    Free cash flow 1-year change

    -76.17%
    CGTX annual free cash flow is down -76.17% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    CGTX annual gross profit margin value is unknown

    Operating margin

    -
    CGTX annual operating profit margin value is unknown

    Net margin

    -
    CGTX annual net profit margin value is unknown

    ROA & ROE

    ROA

    -112.36%
    CGTX annual return on assets is -112.36%

    ROE

    -181.18%
    CGTX annual return on equity is -181.18%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    CGTX price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    CGTX price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.69
    CGTX price to book ratio is 1.69

    PB ratio Sector rank

    52.83%
    CGTX price to book ratio is higher than 52.83% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    CGTX price to sales ratio value is unknown

    PS ratio Sector rank

    -
    CGTX price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $4.97M
    CGTX enterprise value is $4.97 million

    Enterprise value Sector rank

    17.99%
    CGTX enterprise value is higher than 17.99% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.15
    CGTX EV/EBITDA is -0.15

    EV/EBITDA Sector rank

    62.37%
    CGTX EV/EBITDA is higher than 62.37% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    2.65
    CGTX annual current ratio is 2.65

    Quick ratio

    -
    CGTX annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.04
    CGTX annual debt to equity ratio is 0.04

    Interest coverage ratio

    -1357.84
    CGTX annual interest coverage ratio is -1357.84

    Risk & Stability

    Piotroski F-Score

    -
    CGTX piotroski f-score value is unknown

    Altman Z-Score

    -
    CGTX altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    May 8, 25 Chardan Capital
    Buy
    Mar 24, 25 HC Wainwright & Co.
    Buy
    Mar 21, 25 Chardan Capital
    Buy
    Feb 26, 25 Chardan Capital
    Buy
    Dec 19, 24 HC Wainwright & Co.
    Buy
    Dec 19, 24 Chardan Capital
    Buy
    Dec 19, 24 B. Riley Securities
    Buy
    Nov 27, 24 HC Wainwright & Co.
    Buy
    Nov 15, 24 Chardan Capital
    Buy
    Nov 4, 24 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with CGTX included

    Growing Shares Outstanding
    Stocks cheaper than 1 dollar
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Cognition Therapeutics?
    • Does Cognition Therapeutics pay dividends?
    • What sector is Cognition Therapeutics in?
    • What industry is Cognition Therapeutics in?
    • What country is Cognition Therapeutics based in?
    • When did Cognition Therapeutics go public?
    • Is Cognition Therapeutics in the S&P 500?
    • Is Cognition Therapeutics in the NASDAQ 100?
    • Is Cognition Therapeutics in the Dow Jones?
    • When was Cognition Therapeutics's last earnings report?
    • When does Cognition Therapeutics report earnings?
    • Should I buy Cognition Therapeutics stock now?

    What is the ticker symbol for Cognition Therapeutics?

    The ticker symbol for Cognition Therapeutics is NASDAQ:CGTX

    Does Cognition Therapeutics pay dividends?

    No, Cognition Therapeutics does not pay dividends

    What sector is Cognition Therapeutics in?

    Cognition Therapeutics is in the Healthcare sector

    What industry is Cognition Therapeutics in?

    Cognition Therapeutics is in the Biotechnology industry

    What country is Cognition Therapeutics based in?

    Cognition Therapeutics is headquartered in United States

    When did Cognition Therapeutics go public?

    Cognition Therapeutics's initial public offering (IPO) was on October 8, 2021

    Is Cognition Therapeutics in the S&P 500?

    No, Cognition Therapeutics is not included in the S&P 500 index

    Is Cognition Therapeutics in the NASDAQ 100?

    No, Cognition Therapeutics is not included in the NASDAQ 100 index

    Is Cognition Therapeutics in the Dow Jones?

    No, Cognition Therapeutics is not included in the Dow Jones index

    When was Cognition Therapeutics's last earnings report?

    Cognition Therapeutics's most recent earnings report was on May 7, 2025

    When does Cognition Therapeutics report earnings?

    The next expected earnings date for Cognition Therapeutics is Aug 8, 2025

    Should I buy Cognition Therapeutics stock now?

    As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page